381 Seroconversion after anti-SARS-CoV-2 mRNA vaccinations among moderate-to-severe psoriatic patients receiving systemic biologicals

Autor: Piros, É.A., Cseprekál, O., Lukács, A., Hidvégi, B., Medvecz, M., Szabó, Z., Barabás, E., Galajda, N., Miheller, P., Holló, P.
Zdroj: In Journal of Investigative Dermatology December 2022 142(12) Supplement:S246-S246
Databáze: ScienceDirect